Patients with presumed iron overload
Case scenario
The treatment of patients with haemochromatosis and iron overload who are homozygous for the C282Y mutation is straightforward. Treatment includes venesections until patients’ iron levels are reduced to within the normal range.
What is your approach to patients with presumed iron overload (e.g. ferritin levels >600 microgram/L and transferrin saturation >60%) who are heterozygous for the C282Y or H63D mutation? Is the treatment endpoint for patients who are heterozygous for the C282Y or H63D mutation the same as for those who are homozygous for the C282Y mutation, or are these patients classed into different treatment subgroups?
Single article purchases are temporarily unavailable due to site maintenance.
If you would like to purchase an article during this time, please email us at [email protected] with the article details and we'll assist you directly. We'll also let you know when online purchasing is available again.
Thank you for your patience and understanding.